Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mavyret for prevention of HCV transmission in organ transplant
NCT04596475Phase 2Completed
- Sponsor
- University of California, San Diego
- Start
- May 2021
- Primary completion
- Apr 2022
- Modality
- Reversible Covalent Inhibitors, Allosteric Modulators, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of glecaprevir in hepatitis C (HCV), sponsored by University of California, San Diego. Started May 2021; status: completed.
02
Drugs
glecaprevir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT04596475.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04596475.